Pain
📧 Sign up to get email alerts when something new happens for Pain.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-03-04FDA Approved: XTAMPZA ER — Supplemental Application (Collegium Pharmaceutical, Inc.)
The FDA approved a supplemental application for XTAMPZA ER (oxycodone) from Collegium Pharmaceutical, Inc.
-
FDA approval · 2021-03-04FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for hydrocodone bitartrate and acetaminophen tablets from Strides Pharma Science Limited.
-
FDA approval · 2021-03-04FDA Approved: BUPRENORPHINE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
FDA approved a supplemental application for buprenorphine submitted by Rhodes Pharmaceuticals L.P.
-
FDA approval · 2021-03-04FDA Approved: APADAZ — Supplemental Application (Zevra Therapeutics, Inc.)
The FDA approved a supplemental application for APADAZ (benzhydrocodone and acetaminophen) from Zevra Therapeutics, Inc.
-
FDA approval · 2021-03-04FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for the generic oxycodone/acetaminophen product from Amneal Pharmaceuticals of New York LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-03-04FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (SpecGx LLC)
The FDA approved a supplemental application for Hydrocodone Bitartrate and Acetaminophen (hydrocodone/acetaminophen) filed by SpecGx LLC.
-
FDA approval · 2021-03-04FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma)
FDA approved a supplemental application for buprenorphine hydrochloride from PAI Holdings/PAI Pharma, enabling the generic product to be mar…
-
FDA approval · 2021-03-04FDA Approved: TAPENTADOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Tapentadol hydrochloride by Hikma Pharmaceuticals USA Inc., resulting in an updated labeling…
-
FDA approval · 2021-03-04FDA Approved: BUPRENORPHINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for buprenorphine by Actavis Pharma, Inc.
-
FDA approval · 2021-03-04FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved a supplemental application for a hydrocodone bitartrate and acetaminophen product from Lupin Pharmaceuticals.
-
FDA approval · 2021-03-04FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Elite Laboratories, Inc.)
The FDA approved a supplemental application for Hydrocodone Bitartrate and Acetaminophen from Elite Laboratories, Inc., authorizing continue…
-
FDA approval · 2021-03-04FDA Approved: LEVORPHANOL TARTRATE — Supplemental Application (ACERTIS PHARMACEUTICALS, LLC)
FDA approved a supplemental application for levorphanol tartrate by Acetris Pharmaceuticals, LLC (ANDA211484).
-
FDA approval · 2021-03-04FDA Approved: BUTORPHANOL TARTRATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Butorphanol Tartrate from Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2021-03-04FDA Approved: PENTAZOCINE AND NALOXONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved the Sun Pharmaceutical supplemental application for a generic pentazocine and naloxone product. It's an analgesic combination i…
-
FDA approval · 2021-03-04FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approves Upsher-Smith's supplemental application for hydrocodone bitartrate and acetaminophen (ANDA 206484), authorizing a supplemental …
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Brief Cognitive Behavioral Therapy for Chronic Pain [NA]
Completed clinical trial evaluating Brief Cognitive Behavioral Therapy for Chronic Pain; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Celebrex Total Knee Arthroplasty Study [Phase 4]
Phase 4 clinical trial update for Celebrex in total knee arthroplasty terminated.
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: Chronic Neuropathy Following Chemotherapy
A completed clinical trial update on chronic neuropathy following chemotherapy, with results posted in 2021.
-
FDA approval · 2021-02-19FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc)
FDA approved a supplemental application for Camber Pharmaceuticals' methadone hydrochloride, enabling an additional generic product supply u…
-
FDA approval · 2021-02-18FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Aurolife Pharma, LLC)
FDA approved a supplemental application for methadone hydrochloride manufactured by Aurolife Pharma, LLC. This action updates the product's …
-
FDA approval · 2021-02-18FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for methadone hydrochloride from SpecGx LLC.
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®) [Phase 4]
Phase 4 trial comparing intraoperative TAP block with bupivacaine/dexamethasone to liposomal bupivacaine (Exparel) for postoperative pain; s…
-
FDA approval · 2021-02-16FDA Approved: BUPRENORPHINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for buprenorphine from Sun Pharmaceutical Industries under ANDA201760, related to a supplemental app…
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: Epidural Versus Patient-controlled Analgesia for Reduction in Long-term Mortality Following Colorectal Cancer Surgery [Phase 3]
Phase 3 trial comparing epidural versus patient-controlled analgesia for reducing long-term mortality after colorectal cancer surgery; study…
-
FDA approval · 2021-02-12FDA Approved: MORPHINE SULFATE — Original Application (Winder Laboratories LLC)
The FDA approved Winder Laboratories LLC's morphine sulfate product under an Original Application (ANDA). This is a generic opioid analgesic…